The Prognostic and Predictive Role of Epidermal Growth Factor Receptor in Surgical Resected Pancreatic Cancer
The data regarding the prognostic significance of EGFR (epidermal growth factor receptor) expression and adjuvant therapy in patients with resected pancreatic cancer are insufficient. We retrospectively investigated EGFR status in 357 resected PDAC (pancreatic duct adenocarcinoma) patients using tis...
Main Authors: | Meng Guo, Guopei Luo, Chen Liu, He Cheng, Yu Lu, Kaizhou Jin, Zuqiang Liu, Jiang Long, Liang Liu, Jin Xu, Dan Huang, Quanxing Ni, Xianjun Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/17/7/1090 |
Similar Items
-
Prognostic and predictive value of a five-molecule panel in resected pancreatic ductal adenocarcinoma: A multicentre study
by: Jun-Chao Guo, et al.
Published: (2020-05-01) -
Prognostic Factors and Effect of Adjuvant Chemoradiation Following Chemotherapy in Resected Pancreatic Cancer Patients With Lymph Node Metastasis or R1 Resection
by: Jiazhang Xing, et al.
Published: (2021-09-01) -
Hyperdense Pancreatic Ductal Adenocarcinoma: Clinical Characteristics and Proteomic Landscape
by: He Xu, et al.
Published: (2021-02-01) -
Identification and Validation of Circulating Micrornas as Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma Patients Undergoing Surgical Resection
by: Natalia Gablo, et al.
Published: (2020-07-01) -
Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma
by: Yunzhen Qian, et al.
Published: (2020-10-01)